C. VAISLIC, A. BENJELLOUN, J.-N. FABIANI, J.-F. BONNEVILLE, S. CHOCRON Abstract Current treatment of thoracoabdominal aneurysms is associated with significant morbidity and mortality. The most feared and devastating complication is
Multilayer stents in the treatment of thoraco-abdominal residual type B dissection
Case report – Vascular thoracic 3 / Multilayer stents in the treatment of thoraco-abdominal residual type B dissection Sidney Chocrona,*, Claude Vaislicb, Djamel Kailia, Jean-Francois Bonnevillec. Department of Thoracic and
The Multilayer Flow Modulator (MFM) – a radical solution?
Thoracoabdominal aneurysms pose a public health problem that is underestimated in the medical press. Their prevalence can be deduced from a Swedish study conducted between 1958 and 1985 in a
Rescue Percutaneous Coronary Intervention for Acute Ischemic Complications of CABG and non-CABG Cardiac Surgery : A single center hight-volume experience
Conclusion : Following cardiac surgery, emergent PCI revascularization are low-incidence cardiac events but yield high level of complications due to the high-risk cardiac profile of the patients in this setting
One-Year Outcomes Following Repair of Thoracoabdominal Aneurysms With the Multilayer Flow Modulator
Report From the STRATO Trial Claude D. Vaislic, MD1; Jean Noel Fabiani, MD, PhD2; Sidney Chocron, MD, PhD3; Jacques Robin, MD4; Victor S. Costache, MD5; Jean-Pierre Villemot, MD, PhD6; Jean
Economic Impacts of Treatment for Type II or III Thoracoabdominal Aortic Aneurysm in the United States
Mickael Vaislic 1; Claude Vaislic 2,*; Jean-Marc Alsac 3; Amira Benjelloun 4; Sidney Chocron 5; Thierry Unterseeh 6; Jean-Noel Fabiani 7 1. European Company of Strategic Intelligence, Paris, France 2.
